drugset / Trial / NCT04774328

Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

NCT04774328

Phase 1/2 Completed 34 enrolled Concentric Analgesics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Three-Part, Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Adaptive Safety, Pharmacokinetics, and Preliminary Efficacy Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Timeline

Start
2020-09-09
Primary completion
2021-06-15
Completion
2021-06-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator vocacapsaicin Small molecule

Indications

No indication recorded.